Skip to content

Assessment of Contact Lens Wettability Using Wavefront Aberrometry

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02349438
Enrollment
25
Registered
2015-01-28
Start date
2014-12-31
Completion date
2015-05-31
Last updated
2018-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual Acuity

Brief summary

This study will test the feasibility that differences in contact lens wettability can be measured with a wavefront sensor.

Interventions

DEVICEsenofilcon A

A soft spherical contact lens

Sponsors

Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. Healthy males or females that are at least 18 to no more than 40 years of age. 2. The subject must read, understand, and sign the Statement of Informed Consent and receive a fully executed copy of the form. 3. The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol. 4. The subject must possess a wearable pair of spectacles with distance vision correction which provide satisfactory vision. 5. The subject is a current spherical soft contact lens wearer (defined as a minimum of 6 hours of lens wear per week for a minimum of 1 month prior to the study) or has sufficient prior experience with soft contact lens wear (defined as a minimum of 30 days of lens wear during the last 5 years). 6. The subject's vertexed best sphere distance refraction must be between -0.75 and -5.00 D in both eyes. 7. Cylinder refraction less than or equal to -0.75 D in both eyes (any axis). 8. The subject must have corrected visual acuity of 20/20 or better in each eye.

Exclusion criteria

1. Currently pregnant or lactating (subjects who become pregnant during the study will be discontinued). 2. Any ocular or systemic allergies or diseases that may interfere with contact lens wear. 3. Any systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear. 4. Any known hypersensitivity or allergic reaction to contact lens solutions or sodium fluorescein dye. 5. Any previous ocular or intraocular surgery (e.g. radial keratotomy, PRK, LASIK, etc.) 6. Current wearers of rigid or hybrid contact lenses. 7. Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or moderate or above corneal distortion by keratometry. 8. Infectious diseases (e.g. hepatitis, tuberculosis) or an immuno-suppressive disease (e.g. HIV). 9. History of binocular vision abnormality or strabismus. 10. Employee of the investigational clinic (e.g. Investigator, Coordinator, Technician). 11. Clinically significant (grade 3 or 4) corneal edema, pterygium, corneal vascularization, corneal staining, or any other abnormalities of the cornea or conjunctiva which may interfere with the study measurements. 12. Strabismus, suppression or amblyopia. 13. Any ocular infection.

Design outcomes

Primary

MeasureTime frameDescription
Higher Order Root Mean Square (HO RMS) - Near Target in Downgaze With Natural Blinking2 hours post insertionWavefront metric measured by COAS wavefront sensor while subject fixates a near digital device in a down-gaze position with natural blinking. The average HO RMS was reported for each lens. Lower values indicate better outcome.
Higher Order Root Mean Square (HO RMS) - Near Target in Downgaze With Controlled Blink2 hours post insertionWavefront metric measured by COAS wavefront sensor while subject fixates a near digital device in a down-gaze position with controlled blinking. The average HO RMS was reported for each lens. Lower values indicate better outcome.
Higher Order Root Mean Square (HO RMS) - Distance Target in Primary Gaze With Controlled Blink2 hours post insertionWavefront metric measured by COAS wavefront sensor while subject fixates a distant target in primary gaze with controlled blinking. The average HO RMS was reported for each lens. Lower values indicate better outcome.

Countries

Australia

Participant flow

Pre-assignment details

A total of 25 subjects were enrolled into this study. Of the enrolled subjects 4 did not meet the eligibility criteria and 21 were dispensed study lenses. Of the dispensed subjects all 21 completed the study.

Participants by arm

ArmCount
Dispensed
All subjects that were dispensed at least 1 study lens during the course of the study.
21
Total21

Baseline characteristics

CharacteristicDispensed
Age, Continuous23.1 years
STANDARD_DEVIATION 5.43
Race/Ethnicity, Customized
Asian
14 participants
Race/Ethnicity, Customized
White
7 participants
Region of Enrollment
Australia
21 participants
Sex: Female, Male
Female
15 Participants
Sex: Female, Male
Male
6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 210 / 21
serious
Total, serious adverse events
0 / 210 / 21

Outcome results

Primary

Higher Order Root Mean Square (HO RMS) - Distance Target in Primary Gaze With Controlled Blink

Wavefront metric measured by COAS wavefront sensor while subject fixates a distant target in primary gaze with controlled blinking. The average HO RMS was reported for each lens. Lower values indicate better outcome.

Time frame: 2 hours post insertion

Population: All subjects that have completed all study visits.

ArmMeasureValue (MEAN)Dispersion
Senofilcon AHigher Order Root Mean Square (HO RMS) - Distance Target in Primary Gaze With Controlled Blink0.125 micronsStandard Deviation 0.0559
Lotrafilcon BHigher Order Root Mean Square (HO RMS) - Distance Target in Primary Gaze With Controlled Blink0.132 micronsStandard Deviation 0.0511
Primary

Higher Order Root Mean Square (HO RMS) - Near Target in Downgaze With Controlled Blink

Wavefront metric measured by COAS wavefront sensor while subject fixates a near digital device in a down-gaze position with controlled blinking. The average HO RMS was reported for each lens. Lower values indicate better outcome.

Time frame: 2 hours post insertion

Population: All subjects that have completed all study visits.

ArmMeasureValue (MEAN)Dispersion
Senofilcon AHigher Order Root Mean Square (HO RMS) - Near Target in Downgaze With Controlled Blink0.165 micronsStandard Deviation 0.0857
Lotrafilcon BHigher Order Root Mean Square (HO RMS) - Near Target in Downgaze With Controlled Blink0.146 micronsStandard Deviation 0.0567
Primary

Higher Order Root Mean Square (HO RMS) - Near Target in Downgaze With Natural Blinking

Wavefront metric measured by COAS wavefront sensor while subject fixates a near digital device in a down-gaze position with natural blinking. The average HO RMS was reported for each lens. Lower values indicate better outcome.

Time frame: 2 hours post insertion

Population: All subjects that have completed all study visits.

ArmMeasureValue (MEAN)Dispersion
Senofilcon AHigher Order Root Mean Square (HO RMS) - Near Target in Downgaze With Natural Blinking0.159 micronsStandard Deviation 0.0662
Lotrafilcon BHigher Order Root Mean Square (HO RMS) - Near Target in Downgaze With Natural Blinking0.142 micronsStandard Deviation 0.0605

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026